Logo - springer
Slogan - springer

Biomedical Sciences - Pharmacology & Toxicology | DARU Journal of Pharmaceutical Sciences

DARU Journal of Pharmaceutical Sciences

DARU Journal of Pharmaceutical Sciences

Editor-in-Chief: Mohammad Abdollahi

ISSN: 2008-2231 (electronic version)

Journal no. 40199

Learn more about the metrics of this journal
  • Considers outstanding studies from basic research to clinical investigations
  • Indexed in Medline, Scopus, PubMed, Science Citaion Index
  • No Article Processing charges

As an international journal, DARU Journal of Pharmaceutical Sciences considers outstanding studies from basic research to clinical investigations as original articles, systematic reviews, meta-analyses, general reviews, mini-reviews, short communications, and editorials from the global scientific community. Therefore, the journal welcomes submissions from all over the world.

Related subjects » Biochemistry - Pharmacology & Toxicology

Impact Factor: 2.667 (2017) * 

Journal Citation Reports®

Abstracted/Indexed in 

Science Citation Index Expanded (SciSearch), Journal Citation Reports/Science Edition, Medline, PubMedCentral, SCOPUS, Google Scholar, BIOSIS, CAB Abstracts, CNKI, EBSCO Discovery Service, OCLC, ProQuest - Summon

Read this Journal on Springerlink

For authors and editors


  • Journal Citation Reports®
    2017 Impact Factor
  • 2.667
  • Aims and Scope

    Aims and Scope

    Close

    DARU Journal of Pharmaceutical Sciences is a peer-reviewed journal published on behalf of Tehran University of Medical Sciences. The journal encompasses all fields of the pharmaceutical sciences and presents timely research on all areas of drug conception, design, manufacture, classification and assessment.

    The term DARU is derived from the Persian name meaning drug or medicine. This journal is a unique platform to improve the knowledge of researchers and scientists by publishing novel articles including basic and clinical investigations from members of the global scientific community in the forms of original articles, systematic or narrative reviews, meta-analyses, letters, and short communications.

    As of Jan 2018 the journal is published as a hybrid journal (no article processing charges) by Springer. All articles published before 2017 are freely available on springerlink.

  • Submit Online
  • Open Choice - Your Way to Open Access
  • Instructions for Authors
  • Special Issue Call for Papers

    Special Issue Call for Papers

    Close